Established in 2003 in Geneva, DNDi’s office in Switzerland is active in research & development activities, as well as in administrative and support departments, including finance, human resources, IT, policy advocacy, communications, and fundraising.
The team manages projects and partnerships so that new and adapted treatments are developed for sleeping sickness, leishmaniasis, Chagas disease, paediatric HIV, filarial diseases, mycetoma, hepatitis C, cryptococcal meningitis, and dengue.
From 2016 until 2018, DNDi Geneva incubated the WHO-DNDi joint initiative ‘Global Antibiotic Research & Development Partnership (GARDP).
15 Chemin Camille-Vidart
1202 Geneva Switzerland
Tel: + 41 22 906 9230
Fax: +41 22 906 9231